Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: A distinct biological entity with a marked propensity to undergo apoptosis

Blood

Volumn 93, Issue 1, 1999, Pages 315-320

  Chikako, Ito ^b   Kumagai, Masa Aki ^b   Manabe, Atsushi ^b   Coustan Smith, Elaine ^b   Raimondi, Susana C ^b   Behm, Frederick G ^b   Murti, K Gopal ^b   Rubnitz, Jeffrey E ^b   Ching Hon, Pui ^b   Campana, Dario ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; STEM CELL FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CELL GROWTH; CELL SURVIVAL; CHILD; CHROMOSOME 10; CHROMOSOME 4; CHROMOSOME NUMBER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; INFANT; KARYOTYPING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0344718439     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.1.315     Document Type: Article

References (39)

1. Secker-Walker LM, Swansbury GJ, Hardisty RM, Sallan SE, Garson OM, Sakurai M, Lawler SD: Cytogenetics of acute lymphoblastic leukaemia in children as a factor in the prediction of long-term survival. Br J Haematol 52:389, 1982
2. Williams DL, Tsiatis A, Brodeur GM, Look AT, Melvin SL, Bowman WP, Kalwinsky DK, Rivera G, Dahl GV: Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia. Blood 60:864, 1982
3. Michael PM, Garson OM, Ekert H, Tauro G, Rennie GC, Pilkington GR: Prospective study of childhood acute lymphocytic leukemia: Hematologic, immunologic, and cytogenetic correlations. Med Pediatr Oncol 16:153, 1988
4. Trueworthy R, Shuster J, Look T, Crist W, Borowitz M, Carroll A, Frankel L, Harris M, Wagner H, Haggard M: Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group study. J Clin Oncol 10:606, 1992
5. Micallef-Eynaud PD, Eden OB, Grace E, Ellis PM: Cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 10:25, 1993
6. Kobayashi H, Maseki N, Homma C, Sakurai M, Kaneko Y: Clinical significance of chromosome abnormalities in childhood acute lymphoblastic leukemia in Japan. Leukemia 8:1944, 1994
7. A Collaborative Study of the Group Francais de Cytogenetique Hematologique: Cytogenetic abnormalities in adult acute lymphoblastic leukemia: Correlations with hematologic findings outcome. A Collaborative Study of the Group Francais de Cytogenetique Hematologique. Blood 87:3135, 1996
8. Secker-Walker LM, Prentice HG, Durrant J, Richards S, Hall E, Harrison G: Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. Br J Haematol 96:601, 1997
9. Forestier E, Gustafsson G, von Heideman A, Heim S, Hernell O, Mitelman F, Nordenson I, Swolin B, Soderhall S: Prognostic impact of bone marrow karyotype in childhood acute lymphoblastic leukaemia: Swedish experiences 1986-91. Acta Paediatr 86:819, 1997
10. Pui CH: Childhood leukemias. N Engl J Med 332:1618, 1995
11. Look AT, Melvin SL, Williams DL, Brodeur GM, Dahl GV, Kalwinsky DK, Murphy SB, Mauer AM: Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia. Blood 60:959, 1982
12. Whitehead VM, Vuchich MJ, Lauer SJ, Mahoney D, Carroll AJ, Shuster JJ, Esseltine DW, Payment C, Look AT, Akabutu J: Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 80:1316, 1992
13. Synold TW, Relling MV, Boyett JM, Rivera GK, Sandlund JT, Mahmoud H, Crist WM, Pui CH, Evans WE: Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. J Clin Invest 94:1996, 1994
14. Kaspers GJ, Smets LA, Pieters R, Van Zantwijk CH, Van Wering ER, Veerman AJ: Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: Results of an in vitro study. Blood 85:751, 1995
15. Smets LA, Slater RM, Behrendt H, Van't Veer MB, Homan-Blok J: Phenotypic and karyotypic properties of hyperdiploid acute lymphoblastic leukaemia of childhood. Br J Haematol 61:113, 1985
16. Manabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D: Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 79:2370, 1992
17. Manabe A, Murti KG, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Campana D: Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood 83:758, 1994
18. Kumagai M, Manabe A, Pui CH, Behm FG, Raimondi SC, Hancock ML, Mahmoud H, Crist WM, Campana D: Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. J Clin Invest 97:755, 1996
19. Campana D, Behm FG: Leukemia phenotyping: uses for establishing diagnosis, predicting outcome and assessing response to treatment, in Whittaker JA (ed): Leukaemia. Oxford, UK, Blackwell Scientific Publications, 1993, p 203
20. Murti KG, Brown PS, Kumagai M, Campana D: Molecular interactions between human B-cell progenitors and the bone marrow microenvironment. Exp Cell Res 226:47, 1996
21. Manabe A, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Pui CH, Campana D: Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia. Blood 83:1731, 1994
22. Kumagai M, Coustan-Smith E, Murray DJ, Silvennoinen O, Murti KG, Evans WE, Malavasi F, Campana D: Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med 181:1101, 1995
23. Ito C, Evans WE, McNinch L, Coustan-Smith E, Mahmoud H, Pui CH, Campana D: Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. J Clin Oncol 14:2370, 1996
24. Nishigaki H, Ito C, Manabe A, Kumagai M, Coustan-Smith E, Yanishevski Y, Behm FG, Raimondi SC, Pui CH, Campana D: Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemia. Blood 89:3735, 1997
25. Ito C, Ribeiro RC, Behm FG, Raimondi SC, Pui CH, Campana D: Cyclosporin A induces apoptosis in childhood acute lymphoblastic leukemia cells. Blood 91:1001, 1998
26. Consolini R, Pui CH, Behm FG, Raimondi SC, Campana D: In vitro cytotoxicity of docetaxel in childhood acute leukemias. J Clin Oncol 16:907, 1998
27. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182:1545, 1995
28. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F: Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis). Cytometry 27:1, 1997
29. Rubnitz JE, Downing JR, Pui CH, Shurtleff SA, Raimondi SC, Evans WE, Head DR, Crist WM, Rivera GK, Hancock ML, Boyett JM, Buijs A, Grosveld G, Behm FG: TEL gene rearrangement in acute lymphoblastic leukemia: A new genetic marker with prognostic significance. J Clin Oncol 15:1150, 1997
30. Harris MB, Shuster JJ, Carroll A, Look AT, Borowitz MJ, Crist WM, Nitschke R, Pullen J, Steuber CP, Land VJ: Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: A Pediatric Oncology Group study. Blood 79:3316, 1992
31. Raimondi SC, Pui CH, Hancock ML, Behm FG, Filatov L, Rivera GK: Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia 10:213, 1996
32. Pui CH, Raimondi SC, Dodge RK, Rivera GK, Fuchs LA, Abromowitch M, Look AT, Furman WL, Crist WM, Williams DL: Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (greater than 50 chromosomes) acute lymphoblastic leukemia. Blood 73:1963, 1989
33. Manabe A, Yi T, Kumagai M, Campana D: Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. I. Cytotoxicity of interferon alpha in acute lymphoblastic leukemia. Leukemia 7:1990, 1993
34. Salmon SE, Soehnlen B, Dalton WS, Meltzer P, Scuderi P: Effects of tumor necrosis factor on sensitive and multidrug resistant human leukemia and myeloma cell lines. Blood 74:1723, 1989
35. Tsuchiya H, Matsuda I, Kaneko Y: Why does childhood acute lymphoblastic leukemia with hyperdiploidy show a favorable prognosis? Cancer Genet Cytogenet 50:273, 1990
36. Pui CH, Carroll AJ, Head D, Raimondi SC, Shuster JJ, Crist WM, Link MP, Borowitz MJ, Behm FG, Land VJ, Nash MB, Pullen DJ, Look AT: Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood. Blood 76:590, 1990
37. Lahti JM, Xiang J, Heath LS, Campana D, Kidd VJ: PITSLRE protein kinase activity is associated with apoptosis. Mol Cell Biol 15:1, 1995
38. Pasqualini R, Bourdoulous S, Koivunen E, Woods VLJ, Ruoslahti E: A polymeric form of fibronectin has antimetastatic effects against multiple tumor types. Nat Med 2:1197, 1996
39. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J: Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277, 1997